Cargando…

Ivermectin: Potential Role as Repurposed Drug for COVID-19

Severe acute respiratory illness caused by 2019 novel coronavirus (2019-nCoV), officially named severe acute respiratory syndrome coronavirus (SARS-CoV-2) in late December 2019 is an extremely communicable disease. World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) as a pan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixit, Alok, Yadav, Ramakant, Singh, Amit Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Penerbit Universiti Sains Malaysia 2020
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444833/ https://www.ncbi.nlm.nih.gov/pubmed/32863755 http://dx.doi.org/10.21315/mjms2020.27.4.15

Ejemplares similares

Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis
por: Perez-Garcia, Luis A., et al.
Publicado: (2020)

Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
por: Shirazi, Farshad M., et al.
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
por: Rizzo, Emanuele
Publicado: (2020)

Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
por: Wehbe, Zena, et al.
Publicado: (2021)

Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
por: Jermain, Brian, et al.
Publicado: (2020)

Drug repurposing for Dravet syndrome in scn1Lab (−/−) mutant zebrafish
por: Sourbron, Jo, et al.
Publicado: (2019)

The Politicization of Ivermectin Tweets During the COVID-19 Pandemic
por: Diaz, Marlon I, et al.
Publicado: (2022)

Successful Treatment of Brugia pahangi in Naturally Infected Cats with Ivermectin
por: Taweethavonsawat, Piyanan, et al.
Publicado: (2013)

Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study
por: M. Mansour, Suzan, et al.
Publicado: (2021)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
por: Norinder, Ulf, et al.
Publicado: (2020)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
por: Zhang, Hongjun, et al.
Publicado: (2022)

Ivermectin treatment for massive orbital myiasis in an empty socket with concomitant scalp pediculosis
por: Puthran, Neelam, et al.
Publicado: (2012)

A survey of ivermectin resistance in Parascaris species infected foals in south-eastern Poland
por: Studzińska, Maria Bernadeta, et al.
Publicado: (2020)

Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response
por: Pedroso, Célia, et al.
Publicado: (2021)

Repurposing a psychoactive drug for children with cancer: p27(Kip1)-dependent inhibition of metastatic neuroblastomas by Prozac
por: Bibbo’, Sandra, et al.
Publicado: (2020)

Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2
por: Wamae, Claire Njeri
Publicado: (2020)

Ivermectin as a multifaceted drug in COVID-19: Current insights
por: Khandelwal, Ankur, et al.
Publicado: (2021)

Adverse drug reactions and ivermectin in COVID-19
por: Montastruc, Jean-Louis
Publicado: (2022)

Retrospective Analysis of Drug Prescription Statistics in a Tertiary Care Center in India: Recommendations for Promoting Prudent Utilization of Drugs
por: Sahoo, Ajaya Kumar, et al.
Publicado: (2020)

Ivermectin as a potential treatment for COVID-19?
por: Chosidow, Olivier, et al.
Publicado: (2021)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis
por: Holla, Vikram Venkappayya, et al.
Publicado: (2020)

Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review
por: Chakraborty, Debjit, et al.
Publicado: (2020)

Archetype of Olfactory and Gustatory Dysfunction in Breakthrough COVID-19 Illness
por: Sagar, Prem, et al.
Publicado: (2021)

COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics
por: Naasani, Imad
Publicado: (2021)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment
por: Essid, Naceur, et al.
Publicado: (2020)

Perioral Dermatitis Successfully Treated with Topical Ivermectin
por: Charnowski, Sara, et al.
Publicado: (2019)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Advancements in Drug Repurposing: Examples in Psychiatric Medications
por: Okuyama, Ryo
Publicado: (2023)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Exploring the Role of the Public and Private Funded Primary Health Care Facilities for Children in a Pluralistic Health Care Setting of Barbados: One of the English Caribbean Countries
por: Kumar, Alok, et al.
Publicado: (2015)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k3c1or1o94lo8ngt8rq63mmvun